AGIO R&D to Revenue
Agios Pharmaceuticals Inc · R&D to Revenue
AGIO R&D to Revenue
Latest reported618.86%period ending
AGIO FY R&D/Revenue (143.12% → 618.86%)
Latest values, visible window
High-resolution chart · PNG
AGIO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 618.8606% | |
| 825.4863% | |
| 1,077.0719% | |
| 1,965.6601% | |
| 0% | |
| 0% | |
| 348.4751% | |
| 361.6218% | |
| 680.4794% | |
| 315.0046% | |
| 239.9009% | |
| 153.5711% | |
| 213.3318% | |
| 163.455% | |
| 143.1195% |